Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Crescent Biopharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Novavax Inc. June 20, 202566.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 20, 2026 | Novavax Inc. | Option exercise | +18,880 | — | — |
| Jun 12, 2025 | Novavax Inc. | Option exercise | +10,420 | — | — |
| Dec 13, 2024 | Novavax Inc. | Open-market sale | −4,150 | $9.02 | $37,433 |
| Jun 12, 2024 | Novavax Inc. | Option exercise | +6,670 | — | — |
| Mar 29, 2024 | Crescent Biopharma Inc. | Grant or award | +3,334 | $3.00 | $10,002 |
| Dec 29, 2023 | Crescent Biopharma Inc. | Grant or award | +4,238 | $2.36 | $10,002 |
| Sep 30, 2023 | Crescent Biopharma Inc. | Grant or award | +6,667 | $1.50 | $10,001 |
| Jun 10, 2023 | Novavax Inc. | Option exercise | +3,100 | — | — |
| Aug 2, 2022 | Crescent Biopharma Inc. | Inheritance | +7,500 | — | — |
| Feb 15, 2022 | Crescent Biopharma Inc. | Inheritance | +11,641 | — | — |
Questions about Rachel K. King
What boards is Rachel K. King on?
Rachel K. King sits on the boards of Crescent Biopharma Inc., Fulcrum Therapeutics Inc. and Novavax Inc.
How long has Rachel K. King served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.